340B Grantees Spring Conference

340B University

Sunday, May 19

8:00 a.m.–4:45 p.m.

340B University is an educational program designed to meet the practical needs of 340B Program participants and other program stakeholders. Participants learn from 340B subject matter experts, experienced faculty and networking with peers. Continuing education credit is available for pharmacists and pharmacy technicians. There is no fee to attend this training. Breakfast and box lunch are provided.

Enroll today >

Plenary Welcome, Level-Setting, and Conference Overview

Monday, May 20

8:45–9:15 a.m.

Join us for our official welcome, level-setting the environment of CEs and the 340B Drug Pricing Program, as well as hear from our Presenting Sponsors.

CHC Potpourri

Monday, May 20

11:15 a.m.–12:30 p.m.

This session will dive into 340B issues unique to CHCs, including OPAIS registration, BPHC operational site visits, and the sliding fee discount program. Speakers will also provide analysis on the Inflation Reduction Act, its anticipated impact on the Medicaid and Medicare programs, and how that intersects with 340B.

Breakout: Stewardship of Savings

Monday, May 20

3:00–4:15 p.m.

General overview and importance of 340B as a financial driver to support program development at your organization. Topics will include experiences investing savings across in-house development of dispensing pharmacies, clinical programs, and services. Program creation and overview from an administrative, senior leadership perspective, showing the relationship of 340B to program development and investment.

Breakout: Patient Definition and Understanding the Continuum of Care

Tuesday, May 21

11:15 a.m.–12:30 p.m.

This session will demonstrate how using data derived from the 340B Program can improve the continuum of care and close gaps in care that result in improved health plan metrics and patient outcomes.

Breakout: Optimizing Compliance and Transparency of Clinic-Administered Drugs

Tuesday, May 21

3:00–4:15 p.m.

This session will review the pivotal role the Prime Vendor Program plays in the utilization of clinic-administered drugs. Clinic-administered drugs are audited by HRSA to ensure transparent and ethical practices, but the process is slightly different from contract pharmacy audits. Attendees of this presentation will gain valuable insights into HRSA’s audit procedures for clinic-administered drugs. Join us to gain the expertise to apply tools and resources from the Prime Vendor Program to navigate HRSA audits, ensuring transparent and compliant utilization of clinic-administered drugs.

Breakout: Integrating 340B into Your Organizational Strategic Plan

Tuesday, May 21

3:00–4:15 p.m.

This discussion-based session, designed for C-suite and board members, focuses on strategically integrating the 340B Drug Pricing Program. Learn to incorporate 340B into your organization's strategic vision and draft an actionable strategic statement. Engage in discussions emphasizing grantee leadership's role in ensuring compliance and maximizing 340B benefits, culminating in a reflective segment highlighting two key leadership responsibilities.